Skip to main content
The BMJ logoLink to The BMJ
letter
. 1993 Feb 6;306(6874):396. doi: 10.1136/bmj.306.6874.396-b

Monitoring cyclosporin treatment.

C Speed
PMCID: PMC1676448  PMID: 8461707

Full text

PDF

Page 396

396

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dijkmans B. A., van Rijthoven A. W., Goei Thè H. S., Boers M., Cats A. Cyclosporine in rheumatoid arthritis. Semin Arthritis Rheum. 1992 Aug;22(1):30–36. doi: 10.1016/0049-0172(92)90046-g. [DOI] [PubMed] [Google Scholar]
  2. Dougados M., Amor B. Cyclosporin A in rheumatoid arthritis: preliminary clinical results of an open trial. Arthritis Rheum. 1987 Jan;30(1):83–87. doi: 10.1002/art.1780300111. [DOI] [PubMed] [Google Scholar]
  3. Ludwin D., Bennett K. J., Grace E. M., Buchanan W. W., Bensen W., Bombardier C., Tugwell P. X. Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine. Transplant Proc. 1988 Jun;20(3 Suppl 4):367–370. [PubMed] [Google Scholar]
  4. Reynolds D. J., Aronson J. K. ABC of monitoring drug therapy. Cyclosporin. BMJ. 1992 Dec 12;305(6867):1491–1494. doi: 10.1136/bmj.305.6867.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Thomson A. W., Neild G. H. Cyclosporin: use outside transplantation. BMJ. 1991 Jan 5;302(6767):4–5. doi: 10.1136/bmj.302.6767.4. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES